Labcorp Holdings Inc.

NYSE:LH

Medical - Diagnostics & Research

Healthcare
$370.78 -1.33%

-$3.46 today

Market cap
$30.11B
Beta
0.88
P/E (TTM)
22.4
EPS (TTM)
$11.44
Dividend yield
1.12%
52W Low $241.81High $293.72

Volume 0.69M

Average 0.63M

LH Common Stock Repurchased

Cash spent buying back the company's own shares.

Labcorp Holdings Inc.NYSE: LH

Common Stock Repurchased · Q2 FY2026 · quarter ended Jun 2026

Common stock repurchased grows, but more slowly than its trailing trend

Q2 FY2026 common stock repurchased of $353.8M (cash outflow) rose 76.9% year over year, behind the +100.5% change in trailing-twelve-month common stock repurchased. Sequentially, it rose 261.0% from the prior quarter. Over 3 fiscal years it compounded at -26.9% a year.

Context

  • Common stock repurchased amounted to 3.2% of revenue in FY2025, up 1.3 pp from a year earlier.
  • Common stock repurchased grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +76.9% toward the trailing-twelve-month pace of +100.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$353.8M+261.0% QoQ
Last fiscal yearDec 2025
-$450M+79.9% YoY
LTMJun 2026
-$701.8M+100.5% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+76.9%——
1 year+79.9%——
3-year CAGR-26.9%——
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(450M) USD
Year-over-year change
-79.9%

Common Stock Repurchased vs competitors

How LH compares with its peers on the latest reported figures

  • LH's LTM Jun 2026 common stock repurchased of $701.8M is the 2nd largest of the 7 companies compared; the peer median is $254.4M.
  • Its year-over-year change of +100.5% is the 2nd highest of 5, against a peer median of +91.7%.
  • Common stock repurchased amounts to 4.9% of revenue for LH, versus a peer median of 2.3%.
LH Competitors Peer median
Common Stock Repurchased for LH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$7B +600.0%+0.0%14.8%
LHLabcorp Holdings Inc.LTM Jun 2026$701.8M +100.5%-26.9%4.9%
DGXQuest Diagnostics IncorporatedLTM Sep 2026$552M +83.4%-31.6%4.7%
QGENQiagen N.V.LTM Jun 2026$508.79M +71.0%+129.7%24.2%
NTRANatera, Inc.LTM Jun 2026$0 ——0.0%
GHGuardant Health, Inc.LTM Sep 2026$0 +100.0%—0.0%
GRALGRAIL, Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding LH) $254.4M+91.7%+0.0%2.3%

Competitors are the stored peer set for LH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.38B1B379.2M746M877.7M
Depreciation & Amortization577M537.2M577.3M643.5M681.1M
Deferred Income Tax(37.3M)26.3M(78.1M)(20.1M)97.6M
Stock-Based Compensation132.9M116.8M128.7M116.7M125.8M
Change in Working Capital(263.7M)(603.4M)(361.9M)(154.1M)(526.1M)
Accounts Receivables222M15.9M(75.3M)98.5M(122.2M)
Inventory2.8M(45.5M)(700K)(14.6M)(30.2M)
Accounts Payables(10.2M)307.1M(42.4M)210.3M(52.8M)
Other Working Capital(478.3M)(880.9M)(243.5M)(448.3M)(320.9M)
Other Non-Cash Items321.2M875.5M682.5M253.8M384.4M
Operating Cash Flow3.11B1.96B1.33B1.59B1.64B
Capital Expenditures(460.4M)(481.9M)(453.6M)(489.9M)(434.5M)
Acquisitions (Net)(496.9M)(1.16B)(671.5M)(823.9M)(582M)
Purchases of Investments(27.8M)(17.4M)(29M)(55M)(192.4M)
Sales of Investments13.2M8.1M6.7M06.9M
Other Investing Activities87.3M1.4M(24.1M)2M8M
Investing Cash Flow(884.6M)(1.65B)(1.17B)(1.37B)(1.19B)
Debt Repayment(375M)0(300M)1B(775M)
Common Stock Issued51.7M50.6M0054.3M
Common Stock Repurchased(1.67B)(1.15B)(1.04B)(250.1M)(450M)
Dividends Paid0(195.2M)(254M)(243.1M)(240.7M)
Other Financing Activities(74M)23.6M1.53B273.1M(45.6M)
Financing Cash Flow(2.07B)(1.32B)(59.3M)779.9M(1.46B)
Effect of Forex Changes(7.3M)(24.2M)9.9M(17M)24.1M
Net Change in Cash151.9M(1.04B)106.8M981.9M(986.4M)
Free Cash Flow2.65B1.47B874.1M1.1B1.21B

Labcorp Holdings Inc.

NYSE:LH

Intrinsic Alpha fair value

Locked

Current Price

$370.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.